MoneyWorks4Me

Mankind Pharma - Quaterly Results

21 May 2025 Evaluate
A fair growth of 5.93% in the revenue at Rs. 21265.90 millions was reported in the March 2025 quarter as compared to Rs. 20074.70 millions during year-ago period.A slender decline of -13.95% was recorded to Rs. 3824.60  millions from Rs. 4444.40 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 6962.40 millions from 6107.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 21265.90 20074.70 5.93 94978.00 86292.50 10.07 94978.00 86292.50 10.07
Other Income 2193.20 849.60 158.15 4932.10 2705.00 82.33 4932.10 2705.00 82.33
PBIDT 6962.40 6107.40 14.00 30557.60 25367.90 20.46 30557.60 25367.90 20.46
Interest 1622.50 42.90 3682.05 3717.60 163.30 2176.55 3717.60 163.30 2176.55
PBDT 5339.90 6064.50 -11.95 26840.00 25204.60 6.49 26840.00 25204.60 6.49
Depreciation 1052.40 866.20 21.50 3780.10 3352.60 12.75 3780.10 3352.60 12.75
PBT 4287.50 5198.30 -17.52 23059.90 21852.00 5.53 23059.90 21852.00 5.53
TAX 462.90 753.90 -38.60 4217.40 4125.70 2.22 4217.40 4125.70 2.22
Deferred Tax -467.80 -277.60 68.52 -481.90 12.40 -3986.29 -481.90 12.40 -3986.29
PAT 3824.60 4444.40 -13.95 18842.50 17726.30 6.30 18842.50 17726.30 6.30
Equity 412.60 400.60 3.00 412.60 400.60 3.00 412.60 400.60 3.00
PBIDTM(%) 32.74 30.42 7.61 32.17 29.40 9.44 32.17 29.40 9.44
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..